Vistogard
Vistogard | |
---|---|
Term | Vistogard |
Short definition | Vistogard - (pronounced) (VIS toh gard) medicine used in the emergency treatment of adults and children who are receiving too much fluorouracil or capecitabine, or who have cardiac or central nervous system toxicity, or other serious side effects that occur within 4 days of stopping treatment with these medicines. Vistogard may help protect healthy cells from some of the side effects caused by certain cancer drugs. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Vistogard - (pronounced) (VIS toh gard) medicine used in the emergency treatment of adults and children who are receiving too much fluorouracil or capecitabine, or who have cardiac or central nervous system toxicity, or other serious side effects that occur within 4 days of stopping treatment with these medicines. Vistogard may help protect healthy cells from some of the side effects caused by certain cancer drugs. It's a type of chemoprotectant and a type of pyrimidine analogue. Also called PN401, triacetyluridine and uridine triacetate
External links
- Medical encyclopedia article on Vistogard
- Wikipedia's article - Vistogard
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski